Capvizr

Neolix Raises $600 million Series D

Company profile · Healthcare & Life Sciences · Updated October 23, 2025

Neolix raised $600M in Series D financing. Neolix is a Digital Health company focused on meet growing domestic and international demand. The new capital is framed around meet growing domestic and international demand.

Series D$600 millionTotal tracked $600 millionUndisclosed HQ

What it does

Neolix is a Digital Health company focused on meet growing domestic and international demand. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.

Traction

$600 million. Management framed the new capital around meet growing domestic and international demand.

Trend impact

MD-grade thesis held: available source material is not specific enough to support a non-generic investor-economist read without overclaiming.

Funding history

  • October 23, 2025 · Series D · $600 million · undisclosed investors

Products & services

  • Healthcare & Life Sciences workflow monitoring tied to the funding announcement
  • Customer-facing product described on the company website
  • Operational tooling for healthcare & life sciences teams
  • Data capture and reporting across core business processes
  • Team expansion support funded by the latest round
Open Neolix in the interactive Capvizr dashboard →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime